Lazabemide

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Lazabemide
Lazabemide.png
Systematic (IUPAC) name
N-(2-aminoethyl)-5-chloro-pyridine-2-carboxamide
Clinical data
Legal status
  • ℞ (Prescription only)
Routes of
administration		 Oral
Identifiers
CAS Number 103878-84-8
ATC code none
PubChem CID: 71307
IUPHAR/BPS 6640
ChemSpider 64426
UNII 420HD787N9 YesY
KEGG D04681
Chemical data
Formula C8H10ClN3O
Molecular mass 199.64 g/mol

Lazabemide (proposed trade names Pakio, Tempium) is a reversible and selective inhibitor of monoamine oxidase B (MAO-B) that was under development as an antiparkinsonian agent but was never marketed.[1]

References

<templatestyles src="Reflist/styles.css" />

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />



<templatestyles src="Asbox/styles.css"></templatestyles>

Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.
  1. ↑ Lua error in package.lua at line 80: module 'strict' not found.
Retrieved from "https://infogalactic.com/w/index.php?title=Lazabemide&oldid=3585002"